Grand Rapids and Southfield, Mich.-based Corewell Health reported an operating income of $458.6 million (3.2% margin) through the third quarter of 2026, up from a $215.8 million operating income (1.7% margin) during the same period last year.
Corewell’s total revenue was $14.5 billion for the nine months ended Sept. 30, 2026, up 11.2% from $13.1 billion for the same period in 2025.
The system’s total expenses were $14.1 billion, up from $12.8 billion. Salaries, wages and employee benefits were $4.8 billion.
Corewell’s net income was $1.4 billion through the third quarter of 2026, up from $1 billion during the same period last year.
Days cash on hand was 218 days as of Sept. 30, 2026, and long-term debt was $1.7 billion.
Corewell’s total acute discharges rose to 202,548 for the nine months ended Sept. 30. The system said inpatient volumes fell across all care delivery markets in the first quarter, but recovered in the second and third quarters. Average surgeries per business day fell to 201 inpatient and 525 outpatient for the nine months ended Sept. 30, 2026, down from 208 and 549 a year earlier.
The system also saw several deals. In January, Corewell formed a laboratory joint venture with Quest Diagnostics, with Quest holding the majority stake. Corewell received $38.3 million in cash and recognized a one-time, noncash gain of $253.8 million.
Corewell’s health plan, Priority Health, acquired Group Health Cooperative of Eau Claire in Wisconsin in January. This helped grow Priority Health’s membership 7.3% to about 1.4 million. In May, Corewell sold its senior living facilities in Dearborn and Farmington Hills, Mich., to Caring Legacy, recording a one-time cash gain of $43.4 million.